Literature DB >> 3025535

Pituitary cyclic AMP and plasma hormone responses to epinephrine administration in vivo.

E H Mougey, J L Meyerhoff, L L Pennington, C C Kenion, G J Kant.   

Abstract

The present study was conducted to characterize the in vivo effects of epinephrine administration on levels of pituitary cyclic AMP and plasma hormones. Rats were injected with saline or epinephrine bitartrate (1 mg/kg lP) and sacrificed by decapitation 1, 5, 15, 30 or 60 min post-injection. Levels of pituitary cyclic AMP and plasma ACTH, beta-endorphin, beta-LPH, corticosterone and prolactin were determined by radioimmunoassays. The injection procedure itself was somewhat stressful as demonstrated by increased levels of plasma prolactin and ACTH 5 min following either saline or epinephrine injection. This "stress" response was rapid and short-lasting for the pituitary hormones. The response of the adrenal hormone, corticosterone, to saline injection was slower in onset and longer in duration. Pituitary cyclic AMP levels did not increase following saline injection. Epinephrine-injected animals displayed markedly elevated plasma levels of ACTH, beta-endorphin and beta-LPH at 15, 30 and 60 min as compared to control or saline-injected rats. In addition, levels of pituitary cyclic AMP were increased over 10 fold at these times. Levels of plasma prolactin, a stress-responsive hormone, were not significantly increased in epinephrine-injected animals as compared to saline-injected rats indicating that these later responses seem to be specific to epinephrine rather than to stress.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025535     DOI: 10.1016/0024-3205(86)90661-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  The immunomodulating effects of hydrocortisone and adrenaline against the background of blockage of opiate receptors.

Authors:  S V Gein; S P Tendryakova
Journal:  Dokl Biol Sci       Date:  2004 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.